{"id":496521,"date":"2020-07-16T16:00:01","date_gmt":"2020-07-16T16:00:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=496521"},"modified":"2020-07-16T16:00:01","modified_gmt":"2020-07-16T16:00:01","slug":"global-patient-blood-management-market-value-expected-to-reach-1263-billion-by-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-patient-blood-management-market-value-expected-to-reach-1263-billion-by-2023_496521.html","title":{"rendered":"Global Patient Blood Management Market Value Expected To Reach $12.63 Billion By 2023"},"content":{"rendered":"
\"Global<\/a><\/p>\n
\n
Patient Blood Management Market Global Report 2020-30: Covid 19 Growth And Change<\/div>\n<\/div>\n<\/div>\n
Haemonetics Is One Of The Largest Players In The Patient Blood Management Market, According To The Business Research Company\u2019s Patient Blood Management Market Global Report 2020-30: Covid 19 Growth And Change. (Companies Covered: Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Immucor Inc., B. Braun Melsungen AG, Macopharma, bioM\u00e9rieux SA, Asahi Kasei Corporation, KANEKA CORPORATION, Bio-Rad Laboratories Inc.)<\/div>\n

The global patient blood management market is expected to decline from $10.2 billion in 2019 to $9.95 billion in 2020 at a rate of -2.42%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The postponement of non-essential surgical procedures due to the COVID 19 lockdown also impacted the market in 2020. The market is expected to recover and reach $12.63 billion in 2023 at a rate of 8.28%.<\/p>\n

Read More On The Global Patient Blood Management Market Report At – https:\/\/www.thebusinessresearchcompany.com\/report\/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-change<\/a><\/strong><\/p>\n

The patient blood management consists of sales of instruments, accessories, software, reagents and kits used in the management of blood and blood products of patients. Patient blood management is a patient-focused, evidence-based and systematic approach to optimize care of patients who might need a blood transfusion, by optimizing the patients’ own blood, minimizing surgical blood loss and harnessing the patient-specific physiological reserve of anemia. Thus, this reduces the need for allogeneic blood transfusions.<\/p>\n

Global Patient Blood Management Market Segmentation –
<\/strong>1) By Product:<\/strong> Instruments, Accessories, Reagents And Kits, Software.
2) By Component:<\/strong> Plasma, Whole Blood, Red Blood Cells.
3) By Application:<\/strong> Hospital, Clinic, Others.<\/p>\n

Global Patient Blood Management Market Driver –
<\/strong>The increasing number of accidents, trauma cases, and surgical procedures contributed to the growth of the global patient blood management market. According to WHO, 1.35 million people die every year due to road accidents, and low-income and middle-income countries account for 93% of the fatalities occurring in the world due to road accidents.<\/p>\n

Request For A Sample Of The Global Patient Blood Management Market Report At – https:\/\/www.thebusinessresearchcompany.com\/sample.aspx?id=3240&type=smp<\/a><\/strong><\/p>\n

Few Points From The Global Patient Blood Management Market TOC
<\/strong>1. Executive Summary
2. Patient Blood Management Market Characteristics
3. Patient Blood Management Market Size And Growth
3.1. Global Patient Blood Management Historic Market, 2015 – 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Patient Blood Management Forecast Market, 2019 – 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Patient Blood Management Market Segmentation
5. Patient Blood Management Market Regional And Country Analysis
5.1. Global Patient Blood Management Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Patient Blood Management Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion<\/p>\n

Interested to know more about The Business Research Company?<\/strong>
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> The Business Research Company<\/a>
Contact Person:<\/strong> Oliver Guirdham
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +44 20 7193 0708
Address:<\/strong>1st Floor, Anshu Colors Building, Road Number 1
City:<\/strong> London
State:<\/strong> Greater London
Country:<\/strong> United Kingdom
Website:<\/strong> https:\/\/www.thebusinessresearchcompany.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Patient Blood Management Market Global Report 2020-30: Covid 19 Growth And Change Haemonetics Is One Of The Largest Players In The Patient Blood Management Market, According To The Business Research Company\u2019s Patient Blood Management Market Global Report 2020-30: Covid 19 … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-496521","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/496521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=496521"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/496521\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=496521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=496521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=496521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}